Palatin Technologies Inc - Cranbury, New Jersey 08512

Palatin Technologies Inc is categorized under in Cranbury, NJ .

Business Name: Palatin Technologies Inc
Contact Person: Carl Spana, Chief Executive Officer
Address: 4b Cedarbrook Drive, Cranbury, New Jersey 08512
Phone Number: (609) 495-2200
Website Address: palatin.com
Annual Revenue (USD): Unknown
Founding Year: 1996
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:
Related Businesses: The Frederick Purdue Company - Cranbury, NJ 08512
Evenus Pharmaceutical Labs Inc - Cranbury, NJ 08512
Endo Pharmaceuticals Solutions Inc - Cranbury, NJ 08512
Cmic Cmo Usa Corporation - Cranbury, NJ 08512
Purdue Pharma Lp - Cranbury, NJ 08512
Endo Pharmaceuticals Inc - Cranbury, NJ 08512
Sun Pharmaceutical Industries - Cranbury, NJ 08512
Moore Family Realty Inc - Cranbury, NJ 08512
Kos Pharmaceuticals Inc - Cranbury, NJ 08512
Wyeth LLC - Cranbury, NJ 08512
Amicus Therapeutics Inc - Cranbury, NJ 08512
Cocensys Inc - Cranbury, NJ 08512
Pharmacopeia Inc - Cranbury, NJ 08512
Caraco Pharmaceutical Laboratories Ltd - Cranbury, NJ 08512
P F Laboratories Inc - Cranbury, NJ 08512
Evenus Pharmaceutical Laboratories Inc - Cranbury, NJ 08512

The company Palatin Technologies Inc provides BOTH services in the form of from its headquarters in New Jersey. 1 to 4 employees work for Palatin Technologies Inc, and the business now earns Unknown per annum.

Palatin Technologies Inc was launched in 1996 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 . To contact Palatin Technologies Inc, please call Carl Spana, Chief Executive Officer with the phone number (609) 495-2200 or visit its headquarters at 4b Cedarbrook Drive in Cranbury, New Jersey 08512.

The location of the headquarters can also be found using the coordinates 40.334285,-74.504095. Read more details about this business on the webpage palatin.com or follow the company’s social media accounts, on Twitter and on Facebook.